Tranexamic acid has been used for a wide variety of skin conditions, including melasma [
23]. A split-face, double-blind, randomised controlled study of 46 melasma patients treated with a 1927-nm thulium laser on both sides of the face and with tranexamic acid on one side of the face was reported. Significant improvements were observed on both face sides, and there was no statistically significant difference in improvement between the sides [
24]. Similar findings were reported for a randomized comparative split-face study of 30 melasma patients treated with a fractional ablative CO
2laser alone or in combination with tranexamic acid [
25]. Both the combination therapy and the monotherapy resulted in a significant reduction in the Melasma Area and Severity Index (MASI). Patients reported no difference in improvement between the face sides, but the degree of improvement in the MASI score was greater for the side that was treated with the fractional ablative CO
2 laser only. The use of tranexamic acid in combination with fractional ablative CO
2 laser treatment requires further investigation [
25]. A separate study compared microneedling on one side of the face with fractional CO
2 laser treatment in combination with tranexamic acid on the other side of the face in 30 melasma patients, and found no statistically significant difference between the sides [
26]. A randomized, single-blinded, split-face clinical trial of 40 melasma patients treated with topical hydroquinone 4% or a combination of topical hydroquinone 4% and a fractional laser noted improvements in hyperpigmentation and darkness on both face sides, with no significant difference in improvement between sides [
27]. The use of an Er:YAG laser to enhance topical hydroquinone penetration was investigated in 30 melasma patients [
28]. In a split-face study, patients were treated on one side with six sessions involving the application of a fractional Er:YAG laser and then 4% hydroquinone cream, with a 2-week interval between each session, and on the other side with the 4% hydroquinone cream alone. Pretreatment with the Er:YAG laser led to significantly better results (much larger reductions in the MASI) than using hydroquinone alone [
28]. A recent split-face study of 22 patients with melasma compared the effects of a fractional Er:YAG laser combined with a topical steroid to the effects of fractional Er:YAG monotherapy [
29]. Significantly better outcomes were achieved with the combined therapy, with the MASI score decreasing much more than in the Er:YAG monotherapy group [
29].